Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.
about
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumabAllogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients.Mycobacterium tuberculosis peptide E7/HLA-DRB1 tetramers with different HLA-DR alleles bound CD4+ T cells might share identical CDR3 region.T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency
P2860
Abnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@ast
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@en
type
label
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@ast
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@en
prefLabel
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@ast
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@en
P2093
P2860
P1476
Abnormalities of the alphabeta ...... nced myelodysplastic syndrome.
@en
P2093
Edus H Warren
Harlan S Robins
Paulo V Campregher
Santosh K Srivastava
P2860
P304
P356
10.1016/J.EXPHEM.2009.12.004
P577
2009-12-24T00:00:00Z